BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

iCo Therapeutics Inc. 

760 – 777 Hornby Street

Vancouver  British Columbia  V6Z 1S4  Canada
Phone: 604-602-9414 Fax: 604-602-9699


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





 Company News
iCo Therapeutics Inc. Announces Final Eight Month Patient Visit In Phase 2 iDEAL Study 3/5/2014 10:34:59 AM    More...
iCo Therapeutics Inc. Completes C$6.75 Million Equity Financing 1/27/2014 9:14:22 AM    More...
iCo Therapeutics Inc. Announces C$6.75 Million Equity Financing 1/22/2014 7:00:20 AM    More...
iCo Therapeutics Inc. Begins Trading On The OTCQX Marketplace 12/20/2013 11:06:02 AM    More...
iCo Therapeutics Inc. Announces Program And Intellectual Property Advancements For Oral Amphotericin B 12/12/2013 11:25:38 AM    More...
iCo Therapeutics Inc. Grants Options to a Director 9/6/2013 9:04:01 AM    More...
iCo Therapeutics Inc. to Present at the Rodman & Renshaw 2013 Annual Global Investment Conference 9/4/2013 6:33:06 AM    More...
iCo Therapeutics Inc. Announces Second Quarter 2013 Financial Results 8/27/2013 6:12:43 AM    More...
iCo Therapeutics Inc. Announces Completion of Trial Enrollment and Clinical Update for iDEAL Phase 2 Study for the Treatment of Diabetic Macular Edema 6/18/2013 10:13:51 AM    More...
iCo Therapeutics Inc. and JDRF Partner to Investigate iCo-007 in Diabetic Macular Edema 9/26/2011 11:22:10 AM    More...
12345678

//-->